|
Press Releases |
|
 |
|
Monday, September 25, 2023 |
|
致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌 |
武汉友芝友生物制药股份有限公司(“友芝友生物”、或 “公司”,连同其附属公司,统称“集团”;股份代号:2496.HK),今天上午9时正于香港联合交易所有限公司(“联交所”)主板正式上市并开始买卖。 more info >> |
|
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌 |
武漢友芝友生物製藥股份有限公司(「友芝友生物」或 「公司」,連同其附屬公司,統稱「集團」;股份代號:2496.HK),今天上午9時正於香港聯合交易所有限公司(「聯交所」)主板正式上市並開始買賣。 more info >> |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
|
Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. more info >> |
|
Wednesday, September 13, 2023 |
|
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划 |
武汉友芝友生物制药股份有限公司(“友芝友生物”或“公司”,连同其附属公司,统称“集团”;股份代号:2496.HK),一家致力于开发用于治疗癌症相关并发症、癌症及老年性眼科疾病的基于双特异性抗体(双抗)疗法的生物技术公司,今天宣布于香港联合交易所有限公司(“联交所”)主板上市计划。 more info >> |
|
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃 |
武漢友芝友生物製藥股份有限公司(「友芝友生物」或 「公司」,連同其附屬公司,統稱「集團」;股份代號:2496.HK),一家致力於開發用於治療癌症相關併發症、癌症及老年性眼科疾病的基於雙特異性抗體(雙抗)療法的生物技術公司,今天宣佈於香港聯合交易所有限公司(「聯交所」)主板上市計劃。 more info >> |
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK |
Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies to treat cancer-associated complications more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Kincora Secures Full Rights to the Mongolian Copper-Gold Portfolio
Sept 22, 2025 21:39 HKT/SGT
|
|
|
Gamehaus 2.0: A Global, Lifecycle-Integrated Publishing Model that Turns Hit-Making from Bet to Validation
Sept 22, 2025 19:58 HKT/SGT
|
|
|
从全球创意到长期运营:Gamehaus以供应链整合与GBS中台重塑手游发行
Sept 22, 2025 19:58 HKT/SGT
|
|
|
西普尼宣布于港交所主板上市计划 最多募资3.14亿港元
Sept 22, 2025 18:21 HKT/SGT
|
|
|
Focus Graphite Secures Up to $300K in IPON Funding to Advance Patent-Pending Battery Technology
Sept 22, 2025 17:09 HKT/SGT
|
|
|
2025年服貿會 | 以會為橋 共探中醫藥傳承與創新路徑
Sept 22, 2025 16:43 HKT/SGT
|
|
|
HIPINE announces the listing plan on the Main Board of HKEX with a maximum fundraising of approximately HK$314 Million
Sept 22, 2025 15:27 HKT/SGT
|
|
|
西普尼宣佈於港交所主板上市計劃 最多募資3.14億港元
Sept 22, 2025 15:17 HKT/SGT
|
|
|
三菱重工、人事異動を発表
Sept 22, 2025 14:00: JST
|
|
|
GA-ASI 無人機系統總飛行時數突破 900 萬小時
Sept 22, 2025 05:00 HKT/SGT
|
|
|
GA-ASI Line of UAS Passes 9 Million Flight Hours
Sept 22, 2025 05:00 HKT/SGT
|
|
|
耐賦康(R)被納入《2025 KDIGO IgA腎病和IgA血管炎臨床實踐管理指南》 成為指南唯一推薦的IgA腎病一線對因治療藥物
Sept 19, 2025 21:04 HKT/SGT
|
|
|
耐赋康(R)被纳入《2025 KDIGO IgA肾病和IgA血管炎临床实践管理指南》 成为指南唯一推荐的IgA肾病一线对因治疗药物
Sept 19, 2025 21:04 HKT/SGT
|
|
|
Theometrics Global Partners With Acclaimed Designer Cristina Zavati to Launch 'MeaDea by Theo,' Championing Resilience at New York Fashion Week
Sept 19, 2025 21:00 HKT/SGT
|
|
|
MOTER Technologies and NEC Form Strategic Capital Alliance to Advance the Future of Mobility Through Digital Innovation
Sept 19, 2025 19:00 JST
|
|
|
|
More News >> |
|
|
|
|
|